Inogen Inc (INGN) Financial Statements (2025 and earlier)

Company Profile

Business Address 859 WARD DRIVE
GOLETA, CA 93111
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments117,687119,805128,471138,040170,146174,565
Cash and cash equivalents97,920107,444125,492124,608167,687164,137
Short-term investments19,76712,3612,97913,4322,45910,428
Restricted cash and investments3,559     
Receivables36,03740,22342,24148,38051,13553,885
Inventory, net of allowances, customer advances and progress billings24,04824,60121,84024,01530,74438,822
Inventory24,04824,60121,84024,01530,74438,822
Other undisclosed current assets13,46014,56514,51514,83317,19815,875
Total current assets:194,791199,194207,067225,268269,223283,147
Noncurrent Assets
Operating lease, right-of-use asset19,95120,57520,33821,18420,26721,108
Property, plant and equipment47,02249,27050,31649,52549,19545,942
Intangible assets, net (including goodwill)43,34942,74144,64843,93632,88932,887
Goodwill9,7649,83410,0579,86932,88932,887
Intangible assets, net (excluding goodwill)33,58532,90734,59134,067  
Other noncurrent assets3,8063,8193,8253,7832,7772,590
Total noncurrent assets:114,128116,405119,127118,428105,128102,527
TOTAL ASSETS:308,919315,599326,194343,696374,351385,674
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:26,78331,70630,14230,41327,61232,183
Accounts payable14,99515,92213,45415,40813,38918,043
Accrued liabilities26,0192,0392,3802,6442,2451,993
Other undisclosed accounts payable and accrued liabilities(14,231)13,74514,30812,36111,97812,147
Other undisclosed current liabilities45,40242,20442,35429,96931,75531,196
Total current liabilities:72,18573,91072,49660,38259,36763,379
Noncurrent Liabilities
Liabilities, other than long-term debt49,13949,79148,88649,50640,20540,998
Accounts payable and accrued liabilities15,89715,43513,85013,32912,59612,018
Deferred revenue7,0667,6138,2278,8839,3529,801
Deferred income tax liabilities8,0708,1488,5398,421  
Operating lease, liability18,10618,59518,27018,87318,25719,179
Other undisclosed noncurrent liabilities    3,178  
Total noncurrent liabilities:49,13949,79148,88652,68440,20540,998
Total liabilities:121,324123,701121,382113,06699,572104,377
Equity
Equity, attributable to parent187,595191,898204,812230,630274,779281,297
Common stock242423232323
Additional paid in capital324,826323,213320,513321,584319,357316,127
Accumulated other comprehensive income (loss)(138)1881,225(583)74(4)
Accumulated deficit(137,117)(131,527)(116,949)(90,394)(44,675)(34,849)
Total equity:187,595191,898204,812230,630274,779281,297
TOTAL LIABILITIES AND EQUITY:308,919315,599326,194343,696374,351385,674

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues88,76578,02575,89683,96783,63572,162
Cost of revenue(46,028)(43,654)(47,738)(50,203)(49,591)(41,429)
Cost of goods and services sold(38,320)(35,244)(39,936)(42,708)(42,028)(33,964)
Gross profit:42,73734,37128,15833,76434,04430,733
Operating expenses(49,801)(50,645)(57,140)(80,485)(45,812)(52,648)
Operating loss:(7,064)(16,274)(28,982)(46,721)(11,768)(21,915)
Nonoperating income1,4671,5461,8941,4031,9831,762
Investment income, nonoperating1,3331,4031,6021,8011,6461,525
Other nonoperating income (expense)134143292(398)337237
Loss from continuing operations before income taxes:(5,597)(14,728)(27,088)(45,318)(9,785)(20,153)
Income tax expense (benefit)7150533(401)(41)(196)
Net loss available to common stockholders, diluted:(5,590)(14,578)(26,555)(45,719)(9,826)(20,349)

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net loss:(5,590)(14,578)(26,555)(45,719)(9,826)(20,349)
Comprehensive loss:(5,590)(14,578)(26,555)(45,719)(9,826)(20,349)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(326)(1,037)1,808(657)78239
Comprehensive loss, net of tax, attributable to parent:(5,916)(15,615)(24,747)(46,376)(9,748)(20,110)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: